The stock price of Laurus Labs has been on a roller-coaster ride since its IPO. The stock,...
CDMO
Piramal Pharma aims to double its turnover to $2 bn by 2030, driven by its “strategically-positioned” contract...
Strides Pharma Science Limited announced today that it has received approval from equity shareholders and secured creditors...
